Phathom Pharmaceuticals, Inc.
← Back to PHAT Overview

Phathom Pharmaceuticals, Inc. (PHAT)

Solvency & Capital Structure

Total Debt

$2.5M

Net Debt

-$180M

Phathom Pharmaceuticals, Inc. currently has $2.5M in total debt. Net debt is -$180M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

PHATQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-06-300.000.18-0.18Net Cash0.330.8%
2026-03-310.170.18-0.01Net Cash0.3154.5%
2025-12-310.210.130.080.2681.7%
2025-09-300.210.140.070.2487.3%
2025-06-300.570.150.420.25229.6%
2025-03-310.560.210.350.29191.9%
2024-12-310.550.300.260.38146.6%
2024-09-300.520.330.180.39134.1%
2024-06-300.510.280.230.32158.6%
2024-03-310.470.320.150.36131.6%
2023-12-310.140.38-0.24Net Cash0.4133.6%
2023-09-300.230.210.010.2495.5%
2023-06-300.220.25-0.03Net Cash0.2782.8%
2023-03-310.100.13-0.03Net Cash0.1468.3%
2022-12-310.100.16-0.06Net Cash0.1658.9%
2022-09-300.100.20-0.10Net Cash0.2047.4%
2022-06-300.090.21-0.11Net Cash0.2144.2%
2022-03-310.090.14-0.05Net Cash0.1562.1%
2021-12-310.090.18-0.09Net Cash0.1948.2%
2021-09-300.090.22-0.13Net Cash0.2339.4%
2021-06-300.050.21-0.16Net Cash0.2123.3%
2021-03-310.050.24-0.19Net Cash0.2520.2%
2020-12-310.050.29-0.24Net Cash0.3016.6%
2020-09-300.050.23-0.18Net Cash0.2321.3%
2020-06-300.050.25-0.20Net Cash0.2519.3%
2020-03-310.050.26-0.21Net Cash0.2617.7%
2019-12-310.020.24-0.22Net Cash0.269.2%
2019-09-300.120.070.040.08147.8%
2019-06-300.120.080.030.08135.7%
2019-03-310.000.00-0.00Net Cash0.00
2018-12-310.000.000.000.00216.2%